Barriers to Peritoneal Dialysis Selection
Recruitment status was Not yet recruiting
The purpose of this study is to understand what prevents chronic kidney disease patients from making a timely decision about dialysis modality options. This understanding will allow us to develop and implement interventions to assist patients in this turning point so that they can make the right decision for them in a timely enough manner so that each patient can start dialysis in the safest and best way for them. 200 later stage chronic kidney disease patients (20% or less of kidney function remaining) will be asked to participate in the study with the goal of having 150 patients participate in the study.
- 50 % of patients will have made a modality decision when interviewed and patients in the action stage of behavior will be more likely to make a modality selection than patients in earlier stages of behavior change. Barriers to modality selection will act at several levels including patient, provider and health system level and will vary by behavioral stage of change
- 10-15% of patients might choose home dialysis. Knowledge, self efficacy in terms of CKD, education, and income will likely be barriers to home dialysis choice.
Chronic Kidney Disease
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Barriers to Selection and Initiation of Peritoneal Dialysis in the United States|
- Barriers to making a dialysis modality decision [ Time Frame: 1 year ] [ Designated as safety issue: No ]Determine the proportion of patients that made a dialysis modality decision and determine the barriers to being able to make a decision. Determine the proportion of patients choosing home dialysis and barriers associated with choice of home dialysis therapy.
|Study Start Date:||January 2012|
|Estimated Study Completion Date:||April 2013|
|Estimated Primary Completion Date:||January 2013 (Final data collection date for primary outcome measure)|
Chronic kidney disease
Patients with chronic kidney disease (20% or less kidney function remaining. Patients with end stage renal disease who are currently receiving dialysis.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01517841
|United States, Ohio|
|MetroHealth Medical Center- Center for Reducing Health Disparities||Not yet recruiting|
|Cleveland, Ohio, United States, 44109|
|Contact: Anna McGrail firstname.lastname@example.org|
|Principal Investigator:||Suma Prakash, MD||MetroHealth Medical Center|